SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008676
Filing Date
2023-05-09
Accepted
2023-05-09 07:50:33
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xlo-20230331x10q.htm   iXBRL 10-Q 1422314
2 EX-10.2 xlo-20230331xex10d2.htm EX-10.2 232219
3 EX-31.1 xlo-20230331xex31d1.htm EX-31.1 12286
4 EX-31.2 xlo-20230331xex31d2.htm EX-31.2 12179
5 EX-32.1 xlo-20230331xex32d1.htm EX-32.1 8154
  Complete submission text file 0001558370-23-008676.txt   4835664

Data Files

Seq Description Document Type Size
6 EX-101.SCH xlo-20230331.xsd EX-101.SCH 28327
7 EX-101.CAL xlo-20230331_cal.xml EX-101.CAL 36283
8 EX-101.DEF xlo-20230331_def.xml EX-101.DEF 123105
9 EX-101.LAB xlo-20230331_lab.xml EX-101.LAB 294822
10 EX-101.PRE xlo-20230331_pre.xml EX-101.PRE 230673
50 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20230331x10q_htm.xml XML 512850
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40925 | Film No.: 23900027
SIC: 2834 Pharmaceutical Preparations